NTRA Natera, Inc.
Natera, Inc. (NTRA) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is a loss of $0.04 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -10.2% since its last earnings release on November 5, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Natera, Inc.
Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw.
Sector
Healthcare
Industry
Medical Labs & Research
Held By 4 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.